Profile and investment
| Fund type | Open Ended Investment Company |
|---|---|
| Investment style (stocks) | Market Cap: Large Investment Style: Growth |
| Morningstar category | Europe Stock |
| Launch date | 18 Mar 2014 |
| Price currency | USD |
| Domicile | United States |
| Symbol | FHJTX |
| Manager & start date | Allyson Ke 08 Oct 2021 Faris Rahman 08 Oct 2021 |
| Pricing frequency | Daily |
|---|---|
| Total net assets | 624.16m USD As of Mar 31 2024 |
| Share class size | 1.96m USD As of Mar 31 2024 |
| Net expense ratio | 1.69% |
| Front end load | -- |
| Deferred load | 1.00% |
| Maximum Redemption Fee | -- |
| Min. initial investment | 0.00 USD |
| Min. additional investment | -- |
| Initial IRA | -- |
| Additional IRA | -- |
| Available for sale | United States |
More ▼
Top 5 holdings
| Top 5 holdings as a per cent of portfolio | |||
|---|---|---|---|
| 21.82% | 22.15% | 0.00% | 22.15% |
| Category average | % Net assets | % Short | % Long |
| Company | 1 year change | Portfolio weight | Long allocation |
|---|---|---|---|
| Novo Nordisk A/S NOVO B:CPH | +60.52% | 6.45% | |
| ASML Holding NV ASML:AEX | +45.20% | 5.73% | |
| LVMH Moet Hennessy Louis Vuitton SE MC:PAR | -11.09% | 3.42% | |
| AstraZeneca PLC AZN:LSE | +2.69% | 3.33% | |
| SAP SE SAPX:GER | +38.12% | 3.22% | |
| Per cent of portfolio in top 5 holdings: 22.15% |
Asset type
| Non-US stock | 96.92% |
| Cash | 1.53% |
| US stock | 0.68% |
| US bond | 0.00% |
| Non-US bond | 0.00% |
| Other | 0.87% |
Top 5 sectors
| Healthcare | 16.12% |
| Financial Services | 15.83% |
| Technology | 14.11% |
| Industrials | 13.78% |
| Consumer Defensive | 11.57% |
| Other | 26.37% |
Top 5 regions
| Eurozone | 51.24% |
| Europe - ex Euro | 26.49% |
| United Kingdom | 18.99% |
| United States | 0.66% |
| Canada | 0.39% |
Sector and region weightings are calculated using only long position holdings of the portfolio.
